0.70 USD
▲+0.02+6.54%
盘后 0.66 +0.45%
2026-08-03
市值
$20.36M
市盈率
—
EPS
-3.59
股息率
—
52 周区间
0.56 – 4.31
成交量
77.81K
Beta
0.54
目标价
—
52W 低 0.5652W 高 4.31
价格走势
公司简介
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn’s disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn’s) and degenerative disease; and PDA-002 for treating multip...